FULLERTON, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announces upcoming company presentations and investor events. Please mark your calendars accordingly.
* Q3 2006 Earnings Release scheduled for Wednesday, November 1, 2006. * Beckman Coulter 2006 Annual Business Review. The executive management of the company will host one event in New York City, New York, on Tuesday morning, November 7, 2006. Topics to be covered include the company's long-term goals, strategies, market dynamics and growth opportunities: * There will be a live webcast of this event. It is accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com or at www.streetevents.com. When accessing the webcast through the Beckman Coulter site, select "go to IR" under Investor Relations and find the call listed under "What's Ahead." Detailed dial-in information to follow. * To receive full details, please contact Investor Relations at (714) 773-8213 or email cgskoglund@beckman.com * The company will attend the following conferences: * UBS Global Life Sciences Conference - Monday, September 25, 2006 in New York City, New York. * Banc of America - Texas Healthcare Mini-Conference - Thursday, November 9, 2006 in Houston, Texas. * NYSE European Investor Forum - Tuesday, November 14, 2006 in London, England. * Credit Suisse 2006 Healthcare Conference - Wednesday, November 15, 2006 in Phoenix, Arizona. * Lazard Capital Markets Life Sciences Conference - November 28-29, 2006 in New York City, New York. * Piper Jaffray Healthcare Conference - Thursday, November 30, 2006 in New York City, New York. * RBC Capital Markets Healthcare Conference - Wednesday, December 13, 2006 in New York City, New York.
Please refer to the company's website at www.beckmancoulter.com for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead."
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit www.beckmancoulter.com.
Contact: Cynthia Skoglund, (714) 773-8213, cgskoglund@beckman.com or Robert Raynor, (714) 773-7620, rraynor@beckman.com (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.CONTACT: Cynthia Skoglund, +1-714-773-8213, cgskoglund@beckman.com, orRobert Raynor, +1-714-773-7620, rraynor@beckman.com, both of BeckmanCoulter, Inc.
